<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

2 min read

Four Trends to Watch in 2021: Enabling Technology in Orthopedics and Spine

By Elise Wolf on 4/12/21 9:31 AM

COVID-19 threw a curveball to spine and orthopedic implant companies in 2020 with the downturn in elective procedures, but one area that continued to make inroads was enabling technologies. Given increasing advances and expanding adoption of these technologies, even during uncertain times, SmartTRAK highlights some significant trends to watch in 2021, including:

1. Flexible Business Models
Companies with robots (Stryker*, MAKO*, Zimmer Biomet*, ROSA*, Smith & Nephew*, NAVIO*/CORI*, Medtronic*, Mazor X*, Globus*, Excelsius GPS) continued to grow at above-market growth in 2020. Record-breaking robotic and navigation system placements in Q3 and Q420 bode well for ...

Download the complete "Four Trends to Watch in 2021" Article

Continue Reading
2 min read

Healthy Growth in Q420: Q420/FY20 Trauma Market Recap

By Natasha Weeks on 3/22/21 12:16 PM

Healthy growth closes out Q420 as the trauma segment recovers in the second half of the year hitting pre-COVID levels.

Despite the rise in COVID cases during Q4, the Trauma Market fared well resulting in positive YoY revenue gains that represented healthy, pre-COVID level volumes. Trauma players cited another quarter of healthy trauma growth, as the second half of the year ended on an upswing (+5.6% vs. H219). Top US market leaders, DePuy Synthes (49.4% Q420 US share), Stryker (27.3%) and Smith & Nephew (9.8%) all reported improved sequential gains.

Among the many topics covered in the comprehensive Q420/FY20 Trauma Market Recap* are:

Continue Reading
2 min read

COVID-19 Surge Wipe Out: Q420/FY20 Total Joints Market Recap

By Lisa Mahan on 3/17/21 9:21 AM

Surge in COVID-19 Wipes Out Some Procedural Recovery

The surge of COVID-19 cases in Q420 likely brought on by holiday gatherings threatened to wash away the beginning of elective procedure recovery in Q3. In some regions of the US, healthcare facilities once again found themselves underwater as they struggled to care for COVID patients. OUS, Britain and other countries continued to face shutdowns and delay of non-urgent procedures.

Among the many topics covered in the comprehensive Q420/FY20 Total Joints Market Recap* are:

Topics: Orthopedics
Continue Reading
14 min read

R&D Focus: Trials, Patents, Products & Predictions: The Week in Orthopedics

By Thomas Wallick on 2/11/21 9:30 AM

Facing the prevailing headwinds of the pandemic, the MedTech industry presses on with product innovation and plans for the future. SmartTRAK reports daily on the challenges still ahead, covering all aspects of the Orthopedic market: Extremities, OrthoBio, Spine, Computer Assisted Surgery, Total Joints, Trauma, Soft Tissue Fixation and EU Extremities and Trauma.

The following is just a small sampling of the Orthopedic updates from around the world compiled, reviewed and posted in real time last week by our SmartTRAK analysts. We constantly monitor the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, trends, new products, patents, financial data and competitor developments in the global Life Sciences industry.

Arthroscopic Treatment of Chronic Instability of the Lateral Ankle Joint

This study evaluated the clinical effect of total arthroscopic repair of the anterior talofibular ligament in the treatment of chronic instability of the lateral ankle. clinicaltrials.gov

Treatment of varus posteromedial rotatory instability of the elbow w/ an internal joint stabilizer is as effective as a static lateral ex fix allowing for elbow ROM & eliminating many of the complications associated w/ ex fix concluded a cadaveric study. J Shoulder Elbow Surg

Topics: Orthopedics
Continue Reading
2 min read

Beyond COVID: Joint Replacement Trends to Watch

By Lisa Mahan on 2/9/21 8:00 AM

From the global pandemic, shifts in site of care and technologies of interest, to the shift of procedures, these are some of the trends to watch in 2021

In 2020, monitoring the effects that COVID-19 had on joint replacement market quickly dominated the collective consciousness. And as we enter 2021, it is sure to remain top of mind but other trends are worth watching as well. From the shift in site-of-care to technologies of interest, SmartTRAK outlines some of the developments in the joint replacement market.

Among the many things to watch for in 2021 that are included in detail in this Market Outlook analysis article, written by Lisa Mahan, SmartTRAK's VP of Orthopedics, are:

  • Expect Early Market Stops and Starts, Ups and Downs - After the initial wave of COVID-19 in March 2020, elective surgical procedures returned in Q2 and Q320 along with market recovery. However, a rising wave of COVID cases leading into the new year precipitated another round of shutdowns in different regions across the US ...

Topics: Orthopedics
Continue Reading
3 min read

Riding the Wave of COVID-19: Top Trends in Trauma Fixation in 2021

By Natasha Weeks on 1/28/21 2:21 PM

As companies ride the latest wave of COVID-19, SmartTRAK predicts the trends and technologies that will continue to advance the trauma industry in 2021 and 2022.

Trend #1: Procedures Return to Near-Normal Levels in 2021

After the first swell of COVID-19 this past March, elective surgeries took a major hit. As most procedures were postponed during this phase of the pandemic, the trauma segment was impacted to a lesser extent. In early 2020, trauma surgeons reported seeing definite decreases in volumes due to stay-at-home orders, with polytrauma being almost negligible in certain US cities. Geriatric fractures also decreased, but to a lesser extent according to the OTA COVID-19 Webinar discussion. Despite the decrease, surgeons treated the majority of trauma fracture fixation procedures and provided conservative treatment in only a small portion of patients who were in facilities or areas heavily impacted by COVID-19.

Continue Reading
3 min read

Meet Andy Knapik - Senior Analyst, Soft Tissue Fixation

By Sharon O'Reilly on 1/13/21 11:25 AM

We are pleased to announce that Andy Knapik has joined the team at SmartTRAK as Senior Analyst, Soft Tissue Fixation and Arthroscopic Technologies. Andy has 20+ years’ experience in US and International sales and marketing for the orthopedics and sports medicine markets, including 12 years at Smith & Nephew.

Meet Andy Knapik:

What is your role with SmartTRAK? As Senior Analyst for Soft Tissue Fixation and Arthroscopic Technologies, I am currently developing and supporting the Arthroscopic Technologies module, which is new to SmartTRAK, as well as the Sports Medicine Repair module.

What do you like about SmartTRAK? I love the depth and range of experience of all of the analysts. There is a lot of industry knowledge that we can offer customers, and it’s really impressive to me.

What is something special or unique that you bring to SmartTRAK subscribers? I have 20 years of experience in orthopedics working with just about every product that an orthopedist would use from sports medicine and arthroscopy, to trauma and reconstruction. I have also worked in diverse geographies, working in both the US market and internationally in both established as well as emerging markets. So even though my current specialty lies in sports medicine and arthroscopy, there is quite a bit of cross over in general orthopedics that I am able to discuss.

Topics: Orthopedics
Continue Reading
2 min read

A Wild COVID Roller Coaster Ride: Q220 & Q320 Soft Tissue Fixation Market Recap

By Freddy Buntoum on 1/8/21 11:12 AM

Although the COVID-19 roller coaster was a tough ride in Q220, Soft Tissue Fixation was stepping out and looking good in Q320

When an unpredictable COVID-19 roller coaster hit the tracks, companies saw revenue plummet in Q220 as stay-at-home orders were implemented (mid-March) and elective surgeries were canceled or postponed indefinitely. The impact of COVID-19 that forced government-imposed restrictions was felt throughout the 2
Topics: Orthopedics
Continue Reading
2 min read

Trauma Rebounds: Q320 Market Recap

By Natasha Weeks on 1/6/21 9:45 AM

With restrictions lifted during Q320, the trauma segment rebounded from the prior quarter as procedural volumes increased and revenues hit pre-COVID levels.

In the absence of strict COVID restrictions, the jump ball went to the return of healthy trauma volumes during Q320. Major players cited quarterly growth in line with previous years. Q320 picked up the pace with the US Trauma Market leading the charge, up +4.6%, while the EU and ROW declined.

Among the many topics, including company revenues, shares, charts and expert analysis, covered in the comprehensive Q320 Trauma Market Recap* are:

Topics: Orthopedics
Continue Reading
2 min read

Robotic Installations Shatter Expectations: Q320 CAS Ortho Market Recap

By Julianne Burns on 12/28/20 11:50 AM

Orthopedic Robotic Installations Continued to Shatter Expectations in Q320

Orthopedic robotics is still in the early stages of adoption with SmartTRAK estimating that more than 25% of US hospitals have a robot and that fewer than 18% of TKA procedures in the US will have been performed robotically by YE2020. However, Stryker* noted in its Q320 earnings call that orthopedic robotic adoption (MAKO*) has started to reach an inflection point with an uptick in momentum that includes increasing interest, multiple installations in centers, placements into teaching hospitals and a shift to ASCs. Increasing competition from Zimmer Biomet’s* ROSA* and the launch of Smith & Nephew’s* CORI* second-generation robotic platform, has helped to push accounts that were thinking about purchasing a robot to follow through.

Among the many topics, including company revenues, shares, charts and expert analysis, covered in the comprehensive Q320 CAS Ortho Market Recap* are:

Topics: Orthopedics
Continue Reading

    Recent Articles